ESC 365 - Inhibition of Interleukin-6 activity by tocilizumab improves arterial stiffness, LV myocardial deformation and endothelial glycocalyx in patients with rheumatoid arthritis.

ESC Premium Access

Inhibition of Interleukin-6 activity by tocilizumab improves arterial stiffness, LV myocardial deformation and endothelial glycocalyx in patients with rheumatoid arthritis.

Session: Endothelial function and the microcirculation

Topic: Endothelial function

Speaker: Doctor I. Ikonomidis (Athens, GR)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

5 presentations

3 followers

4 more presentations in this session

State of the Art: endothelial function and the microcirculation

Speaker: Professor D. Duncker (Rotterdam, NL)

Red blood cells from patients with type 2 diabetes mellitus induce vascular endothelial dysfunction via a mechanism involving vascular arginase I and reactive oxygen species

Speaker: Doctor Z. Zhou (Stockholm, SE)

Akap1 modulates endothelial cells function, arterial systolic blood pressure and vascular reactivity

Speaker: Doctor F. Cattaneo (Naples, IT)

The importance of endothelial dysfunction in clinical practice

Speaker: Professor J. Kaski (London, GB)

Access the full session

Endothelial function and the microcirculation

Speakers: Doctor I. Ikonomidis, Professor D. Duncker, Doctor Z. Zhou, Doctor F. Cattaneo, Professor J. Kaski

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources